Assessment and Posttest
CE Original Date: June 1, 2010
CE Renewal Date: June 1, 2012
CE Expiration Date: June 1, 2014
Download Printer-Friendly version [PDF - 809 KB]
|Previous Section||Next Section|
ATSDR seeks feedback on this course so we can assess its usefulness and effectiveness. We ask you to complete the online assessment questionnaire.
To receive continuing education credit, you must complete the assessment and posttest online.
|Credits credits pending|
The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.7 contact hours.
The Centers for Disease Control and Prevention is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is a designated event for the CHES to receive 2.0 Category I contact hours in health education, CDC provider number GA0082.
The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.2 IACET CEU's for this program.
To complete the assessment and posttest, go to Training and Continuing Education Online and follow the instructions on that page.
You can immediately print your continuing education certificate from your personal transcript online. No fees are charged.
1. The learning outcomes (objectives) were relevant to the goal(s) of the course
2. The content was appropriate given the stated objectives of the course
3. The content was presented clearly
4. The learning environment was conducive to learning
5. The delivery method (e.g., web, video, DVD, etc.) helped me learn the material
6. The instructional strategies helped me learn the material.
7. Overall, the quality of the course materials was excellent
8. The difficulty level of the course was
9. Overall, the length of the course was
10. The availability of CE credit influenced my decision to participate in this activity
11. As a result of completing this educational activity, it is likely that I will make changes in my practice
12. I am confident I can better provide appropriate clinical care for patients exposed to environmental hazards as described in this course
13. I intend to apply recommendations from this course in my clinical practice
14. The content expert(s) demonstrated expertise in the subject matter
15. Do you feel this course was commercially biased? If yes, please explain
16. Please describe any technical difficulties you experienced with the course.
17. What could be done to improve future offerings?
18. Do you have any further comments?
Choose the one best answer
1. What is radon?
2. Which is/are the main source of human exposure to alpha radiation?
3. What is the main source of indoor radon gas?
4. Which of the following is the best method of determining whether you are potentially exposed to increased environmental levels of radon in your home?
5. The most important route of exposure to radon is
6. What is the only established human health effect currently associated with exposure to increased levels of radon?
7. Which of the following best identifies populations having the highest risk of exposure to increased radon levels?
8. In 2007, exposure to radon was considered
9. What is the relative risk of lung cancer mortality from radon exposure for persons who smoke cigarettes as compared with those who have never smoked?
10. At which of the following levels would EPA recommend indoor radon remediation?
11. How should adults and children potentially exposed to increased radon levels be clinically assessed?
12. Which of the following is clinically indicated in the treatment of radon toxicity?
13. Which of the following is a way to assess potential increased exposure to radon gas?
14. What should a patient do if home radon levels exceed the recommended EPA maximum?
15. Which of the following should be considered in the management of a patient with positive pulmonary findings from the initial clinical assessment when exposure to increased levels of radon are suspected or known?
To review content relevant to the post-test questions, see:
|Previous Section||Next Section|